CB-1 Targeters For Obesity Dropping Fast

Psychiatric risk makes Merck’s taranabant the latest casualty.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet